Biocytogen’s fully human antibody will support the development of SOT109, SOTIO’s new ADC candidate aimed at the treatment of colorectal cancer and other gastrointestinal (GI) cancers. Biocytogen’s ...
A mum-of-three who claimed her GP mistook symptoms of bowel cancer for a urinary infection three times has urged others to be aware of the tell-tale signs of the disease. Zoe Gardner-Lawson ...
SOT109 has demonstrated broad preclinical activity in multiple models of colorectal cancer. SOT109 utilizes proprietary and clinically validated ADC platform technology for site-specific ...
Biocytogen’s fully human antibody will support the development of SOT109, SOTIO’s new ADC candidate aimed at the treatment of colorectal cancer and other gastrointestinal (GI) cancers.